Exploring the Efficacy of Benralizumab in Chronic Eosinophilic Pneumonia Following Corticosteroid Therapeutic Failure: A Case Report
Sofia De La O Villalobos, Pablo Olivas Melendez, Adriana Saenz Ramirez, Mariana Gonzalez Plascencia, Isai R Castillo Cabrera
TL;DR
This case report explores the use of benralizumab in a patient with chronic eosinophilic pneumonia who did not respond to corticosteroids.
Contribution
The novelty lies in reporting benralizumab's potential efficacy in treating corticosteroid-resistant chronic eosinophilic pneumonia.
Findings
The patient's condition did not improve with corticosteroid therapy.
Benralizumab was considered as an alternative treatment option.
Abstract
Chronic eosinophilic pneumonia is a rare idiopathic disease characterized by eosinophilic infiltrates in the alveoli and interstitial lung spaces. There are no specific diagnostic tests for this condition, but it is suspected in patients presenting with dyspnea, cough, a tomographic pattern of consolidations, peripheral ground-glass opacities, and peripheral eosinophilia. This report presents the case of a male patient with chronic eosinophilic pneumonia that was unresponsive to corticosteroid treatment.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Potassium and Related Disorders · Pneumocystis jirovecii pneumonia detection and treatment